arrow_back Back Filing freshness 10-Q FY 2026 SEC EDGAR

download Export Data

BIOTRICITY INC.

BTCY

— Price unavailable

15 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Bearish

auto_awesome

Analytical Summary

BIOTRICITY INC. faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth 16.0% ↗

Op. Margin 10.6% ↗

ROIC -3.9% ↘

FCF / Share $-0.03 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$16.00M

↑ +16.0% —

Net Income Profit after all expenses

$-2.40M

↑ +71.5% —

Operating Margin Operating profit as % of sales

10.6%

↑ +159.5% 67th

FCF / Share Free cash flow per share

$-0.03

↑ +76.2% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↓

Financial Health

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗	FY 2021 Mar 31, 2021 10-K ↗	FY 2020 Mar 31, 2020 10-K ↗	FY 2019 Mar 31, 2019 10-K ↗	FY 2018 Mar 31, 2018 10-K ↗	FY 2017 Mar 31, 2017 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 29, 2012 10-K ↗
Revenue Growth YoY (%)	16.0% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+100%)	14.3% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+79%)	25.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+214%)	26.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+225%)	126.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1475%)	138.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1634%)	256.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3100%)	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	79.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	66.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-341.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	43.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-51.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	71.5% Excellent ↑ Excellent Improving Year-over-year change in net income	40.3% Excellent ↑ Excellent Improving Year-over-year change in net income	24.5% Good ↑ Good Improving Year-over-year change in net income	35.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-88.0% Weak ↓ Weak Declining Year-over-year change in net income	-40.0% Weak ↓ Weak Declining Year-over-year change in net income	-28.8% Weak ↓ Weak Declining Year-over-year change in net income	0.4% Caution ↑ Caution Improving Year-over-year change in net income	-10.4% Weak ↑ Weak Improving Year-over-year change in net income	-50.6% Weak ↑ Weak Improving Year-over-year change in net income	-1850.5% Weak Weak Year-over-year change in net income	-191.9% Weak Weak Year-over-year change in net income	—	—	—
FCF Growth YoY (%)	76.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	85.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-185.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	22.0% Good Good Year-over-year change in free cash flow	-13.2% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	18.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	21.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	52.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	89.4% Excellent Excellent Compound annual revenue growth over 3 years	167.8% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	36.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	57.6% Excellent Excellent Compound annual revenue growth over 5 years	97.8% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗	FY 2021 Mar 31, 2021 10-K ↗	FY 2020 Mar 31, 2020 10-K ↗	FY 2019 Mar 31, 2019 10-K ↗	FY 2018 Mar 31, 2018 10-K ↗	FY 2017 Mar 31, 2017 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 29, 2012 10-K ↗
Operating Margin (%) (%)	10.6% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-30%)	-17.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-218%)	-73.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-588%)	-159.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1166%)	-218.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1558%)	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-15.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-225%)	-61.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-609%)	-116.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1074%)	-193.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1713%)	-380.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3273%)	-457.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3914%)	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-4.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-17.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-55.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-140.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-198.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-327.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.30x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.28x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.52x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.38x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.18x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.09x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗	FY 2021 Mar 31, 2021 10-K ↗	FY 2020 Mar 31, 2020 10-K ↗	FY 2019 Mar 31, 2019 10-K ↗	FY 2018 Mar 31, 2018 10-K ↗	FY 2017 Mar 31, 2017 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 29, 2012 10-K ↗
Return on Invested Capital (%)	-3.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	6.0% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	22.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	61.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	616.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	26.2% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-43.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-148.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-236.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-100.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	6.9% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-54%)	26.3% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+75%)	44.8% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+199%)	94.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+527%)	—	226.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1411%)	—	—	—	178.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1087%)	—	109.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+628%)	53.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+256%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗	FY 2021 Mar 31, 2021 10-K ↗	FY 2020 Mar 31, 2020 10-K ↗	FY 2019 Mar 31, 2019 10-K ↗	FY 2018 Mar 31, 2018 10-K ↗	FY 2017 Mar 31, 2017 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 29, 2012 10-K ↗
Interest Coverage (x)	0.59x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-0.68x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.92x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.38x Weak Weak Operating income divided by interest expense Optimal: > 5x	-13.04x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-149.79K	$-365.14K	$-786.06K	$-570.46K	$-12.07M	$-2.20M	$-949.85K	$-63.65K	—	$-424.87K	$-410.60K	$-4.41K	$0.00	$0.00	$0.00

📊 What does each share earn? 6 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗	FY 2021 Mar 31, 2021 10-K ↗	FY 2020 Mar 31, 2020 10-K ↗	FY 2019 Mar 31, 2019 10-K ↗	FY 2018 Mar 31, 2018 10-K ↗	FY 2017 Mar 31, 2017 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 29, 2012 10-K ↗
Revenue per Share (USD)	$0.59	$0.64	$1.34	$0.19	$0.17	$0.09	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.12	$-0.56	$-1.66	$-0.38	$-0.67	$-0.44	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.03	$-0.11	$-0.74	$-0.26	$-0.33	$-0.30	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-1.21	$-1.23	$-3.36	$-0.39	$-0.04	$-0.19	$-0.09	$-0.06	$0.01	$-0.24	$-0.08	$-0.03	$-0.04	—	—
Tangible Book Value per Share (USD)	$-1.21	$-1.23	$-3.36	$-0.39	$-0.04	$-0.19	$-0.09	$-0.06	$0.01	$-0.24	$-0.08	$-0.03	$-0.04	—	—
Basic Weighted Avg Shares (shares)	27.30M	21.52M	8.99M	51.96M	45.45M	37.52M	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗	FY 2021 Mar 31, 2021 10-K ↗	FY 2020 Mar 31, 2020 10-K ↗	FY 2019 Mar 31, 2019 10-K ↗	FY 2018 Mar 31, 2018 10-K ↗	FY 2017 Mar 31, 2017 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 29, 2012 10-K ↗
Working Capital (USD)	$-31.28M	$-16.00M	$-18.23M	$-6.44M	$10.46M	$-6.17M	$-2.14M	$-1.81M	—	—	—	—	—	—	—
Total Equity (USD)	$-34.68M	$-32.01M	$-31.47M	$-19.85M	$-2.14M	$-6.83M	$-3.00M	$-1.78M	$173.25K	$-4.38M	$-1.24M	$-243.57K	$-170.56K	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2026 Mar 31, 2026 10-K ↗	FY 2025 Mar 31, 2025 10-K ↗	FY 2024 Mar 31, 2024 10-K ↗	FY 2023 Mar 31, 2023 10-K ↗	FY 2022 Mar 31, 2022 10-K ↗	FY 2021 Mar 31, 2021 10-K ↗	FY 2020 Mar 31, 2020 10-K ↗	FY 2019 Mar 31, 2019 10-K ↗	FY 2018 Mar 31, 2018 10-K ↗	FY 2017 Mar 31, 2017 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Aug 31, 2015 10-K ↗	FY 2014 Aug 31, 2014 10-K ↗	FY 2013 Aug 31, 2013 10-K ↗	FY 2012 Aug 29, 2012 10-K ↗
Sales/Revenue/Turnover (USD)	$16.00M	$13.79M	$12.06M	$9.64M	$7.65M	$3.38M	$1.42M	$398.20K	—	—	—	—	—	—	—
Depreciation Expense (USD)	$5.95K	$5.95K	$5.95K	$5.95K	$2.31K	—	—	—	—	—	—	$1.00K	$0.00	—	—
Net Income, GAAP (USD)	$-2.40M	$-8.42M	$-14.09M	$-18.66M	$-29.13M	$-15.49M	$-11.07M	$-8.59M	$-8.62M	$-7.81M	$-5.19M	$-265.87K	$-91.07K	—	—
Operating Cash Flow (USD)	$-718.96K	$-2.38M	$-6.69M	$-13.55M	$-15.16M	$-11.08M	$-7.86M	$-5.22M	$-4.87M	$-3.75M	$-1.96M	$-47.06K	$-8.22K	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 15 years · 54 quarters

BIOTRICITY INC.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BTCY with peers